Short answer
AdaptHealth Corp. (AHCO) filed an 8-K current report with the SEC on May 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 5.02 (Departure/Election of Directors or Officers), Item EX-99.1 (Exhibit EX-99.1). Q1 2026 financial results for quarter ended March 31, 2026.
AdaptHealth Corp. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q1 2026 financial results for quarter ended March 31, 2026
- Press release issued May 5, 2026 under Regulation FD
- Detailed results and management commentary in Exhibit 99.1
Item 5.02 · Departure/Election of Directors or Officers
- COO Toby Scott Barnhart terminated without Cause on May 4, 2026, triggering contractual severance and other benefits
- Daniel McFadden, existing Chief Business Systems Officer, appointed COO effective May 4, 2026
- No change to McFadden’s compensation as of the filing date, limiting immediate cost impact
- No disclosed family relationships, appointment arrangements, or related-party transactions involving McFadden
Item EX-99.1 · Exhibit EX-99.1
- Q1 revenue $819.8M, up 5.4%, with organic growth 9.1% across all four segments
- Adjusted EBITDA $121.2M, down 5.3%; margin fell to 14.8% from 16.4% amid $12.0M elevated transition labor costs
- Net loss widened to $16.0M from $7.2M; diluted loss per share increased to $0.12 from $0.05
- Free cash flow deteriorated to negative $27.5M from negative $0.1M, reflecting $121.2M equipment purchases and $84.7M acquisitions
- 2026 revenue guidance raised to $3.45B-$3.52B; EBITDA guidance remains $680M-$730M and free cash flow $175M-$225M
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other AdaptHealth Corp. 8-K filings
Get the next AHCO 8-K as it lands
Follow AHCO for push alerts, or ask the research agent what this filing means.